Search

Now showing items 1-5 of 5

Distribution of cardiovascular risk among patients with dyslipidemia in Turkey: results from a delphi panel

Yilmaz, M. B.; Cinar, O.; Gungor, B.; Kayikcioglu, M.; Oz, T. K.; Ozdogan, O.; Sinan, U. Y.; Temizhan, A.; Yuksel, U. C.; Tokgozoglu, L. (ELSEVIER IRELAND LTD, 2022)

Distribution of cardiovascular risk among patients with dyslipidemia in Turkey: results from a delphi panel

Management of secondary prevention patients with ldl-cholesterol levels < 70mg/Dl (1.8mmol/L): an analysis based on delphi panel approach

Kayikcioglu, M.; Temizhan, A.; Gungor, B.; Yilmaz, M. B.; Ozdogan, O.; Cinar, O.; Oz, T. K.; Sinan, U. Y.; Yuksel, U. C.; Tokgozoglu, L. (ELSEVIER IRELAND LTD, 2022)

Management Of Secondary Prevention Patients With Ldl-Cholesterol Levels < 70mg/Dl (1.8mmol/L): An Analysis Based On Delphi Panel Approach

Management of patients with ldl-cholesterol levels > 190mg/Dl (4.9mmol/L) in Turkey: an analysis based on delphi panel approach

Kayikcioglu, M.; Yuksel, U. C.; Yilmaz, M. B.; Temizhan, A.; Sinan, U. Y.; Ozdogan, O.; Oz, T. K.; Kus, M.; Gungor, B.; Tokgozoglu, L. (ELSEVIER IRELAND LTD, 2022)

Management Of Patients With Ldl-Cholesterol Levels > 190mg/Dl (4.9mmol/L) In Turkey: An Analysis Based On Delphi Panel Approach

Hospitalization features and mortality rates of very high-risk patients with dyslipidemia in Turkey

Ozdogan, O.; Gungor, B.; Kayikcioglu, M.; Oz, T. K.; Ozcan, K.; Sinan, U. Y.; Temizhan, A.; Yilmaz, M. B.; Yuksel, U. C.; Tokgozoglu, L. (ELSEVIER IRELAND LTD, 2022)

Hospitalization features and mortality rates of very high-risk patients with dyslipidemia in Turkey

First diagnosis and follow up features of patients with dyslipidemia in Turkey

Ozdogan, O.; Gungor, B.; Kayikcioglu, M.; Oz, T. K.; Ozcan, K.; Sinan, U. Y.; Temizhan, A.; Yilmaz, M. B.; Yuksel, U. C.; Tokgozoglu, L. (ELSEVIER IRELAND LTD, 2022)

First diagnosis and follow up features of patients with dyslipidemia in Turkey

Search

Filters

Distribution of cardiovascular risk among patients with dyslipidemia in Turkey: results from a delphi panel

Management of secondary prevention patients with ldl-cholesterol levels < 70mg/Dl (1.8mmol/L): an analysis based on delphi panel approach

Management of patients with ldl-cholesterol levels > 190mg/Dl (4.9mmol/L) in Turkey: an analysis based on delphi panel approach

Hospitalization features and mortality rates of very high-risk patients with dyslipidemia in Turkey

First diagnosis and follow up features of patients with dyslipidemia in Turkey